Download PDF
Semin Thromb Hemost 2010; 36(8): 824-832
DOI: 10.1055/s-0030-1267036
© Thieme Medical Publishers

Microparticle Sizing and Counting Using Light Scattering Methods

Don A. Gabriel1 , 2 , Karen Giordano1
  • 1University of North Carolina School of Medicine, Chapel Hill, North Carolina
  • 2Invitrox, Inc., Durham, North Carolina
Further Information

Publication History

Publication Date:
03 November 2010 (online)

    Permissions and Reprints

ABSTRACT

New light scattering methods offer many advantages to particle size distribution characterization. In addition to ease of operation, speed, and accuracy, the particle size, particle surface characteristics, interaction of the surface with specific ligands, and hydrodynamic volume of the particle are easily obtained. Extensions of these methods also permit the assessment of surface reactions in real time and without reporter group conjugation to the reactant. These methods offer the ability to examine binding constants and kinetics of binding without chemical modification and offer true advantages in product development and clinical diagnostics and therapeutic monitoring.

KEYWORDS

Quasi elastic light scattering - Mie scattering - electrophoresis - microparticles - particle sizing

REFERENCES

  • 1 Zwaal R FA, Schroit A J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells.  Blood. 1997;  89(4) 1121-1132
    PubMedGoogle Scholar
  • 2 Nomura S, Ozaki Y, Ikeda Y. Function and role of microparticles in various clinical settings.  Thromb Res. 2008;  123(1) 8-23
    CrossrefPubMedGoogle Scholar
  • 3 Piccin A, Murphy W G, Smith O P. Circulating microparticles: pathophysiology and clinical implications.  Blood Rev. 2007;  21(3) 157-171
    CrossrefPubMedGoogle Scholar
  • 4 Fox J E, Austin C D, Boyles J K, Steffen P K. Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane.  J Cell Biol. 1990;  111(2) 483-493
    CrossrefPubMedGoogle Scholar
  • 5 Connor J, Pak C H, Zwaal R FA, Schroit A J. Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. Evidence for an ATP-dependent and protein-mediated process.  J Biol Chem. 1992;  267(27) 19412-19417
    PubMedGoogle Scholar
  • 6 Diaz C, Schroit A J. Role of translocases in the generation of phosphatidylserine asymmetry.  J Membr Biol. 1996;  151(1) 1-9
    CrossrefPubMedGoogle Scholar
  • 7 McLaughlin P J, Gooch J T, Mannherz H G, Weeds A G. Structure of gelsolin segment 1-actin complex and the mechanism of filament severing.  Nature. 1993;  364(6439) 685-692
    CrossrefPubMedGoogle Scholar
  • 8 Beleznay Z, Zachowski A, Devaux P F, Navazo M P, Ott P. ATP-dependent aminophospholipid translocation in erythrocyte vesicles: stoichiometry of transport.  Biochemistry. 1993;  32(12) 3146-3152
    CrossrefPubMedGoogle Scholar
  • 9 Zwaal R FA, Comfurius P, Bevers E M. Mechanism and function of changes in membrane-phospholipid asymmetry in platelets and erythrocytes.  Biochem Soc Trans. 1993;  21(2) 248-253
    PubMedGoogle Scholar
  • 10 Kelton J G, Warkentin T E, Hayward C P, Murphy W G, Moore J C. Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles.  Blood. 1992;  80(9) 2246-2251
    PubMedGoogle Scholar
  • 11 George F D. Microparticles in vascular diseases.  Thromb Res. 2008;  122(Suppl 1) S55-S59
    CrossrefPubMedGoogle Scholar
  • 12 Chironi G N, Boulanger C M, Simon A, Dignat-George F, Freyssinet J M, Tedgui A. Endothelial microparticles in diseases.  Cell Tissue Res. 2009;  335(1) 143-151
    CrossrefPubMedGoogle Scholar
  • 13 Mallat Z, Benamer H, Hugel B et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.  Circulation. 2000;  101(8) 841-843
    CrossrefPubMedGoogle Scholar
  • 14 Morel O, Hugel B, Jesel L et al. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists.  J Thromb Haemost. 2004;  2(7) 1118-1126
    CrossrefPubMedGoogle Scholar
  • 15 Matsumoto N, Nomura S, Kamihata H, Kimura Y, Iwasaka T. Increased level of oxidized LDL-dependent monocyte-derived microparticles in acute coronary syndrome.  Thromb Haemost. 2004;  91(1) 146-154
    PubMedGoogle Scholar
  • 16 Chirinos J A, Heresi G A, Velasquez H et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism.  J Am Coll Cardiol. 2005;  45(9) 1467-1471
    CrossrefPubMedGoogle Scholar
  • 17 Simak J, Gelderman M P, Yu H, Wright V, Baird A E. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome.  J Thromb Haemost. 2006;  4(6) 1296-1302
    CrossrefPubMedGoogle Scholar
  • 18 Ederhy S, Di Angelantonio E, Mallat Z et al. Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation.  Am J Cardiol. 2007;  100(6) 989-994
    CrossrefPubMedGoogle Scholar
  • 19 Boulanger C M, Scoazec A, Ebrahimian T et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction.  Circulation. 2001;  104(22) 2649-2652
    CrossrefPubMedGoogle Scholar
  • 20 Rozmyslowicz T, Majka M, Kijowski J et al. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV.  AIDS. 2003;  17(1) 33-42
    CrossrefPubMedGoogle Scholar
  • 21 Kim H K, Song K S, Chung J H, Lee K R, Lee S N. Platelet microparticles induce angiogenesis in vitro.  Br J Haematol. 2004;  124(3) 376-384
    CrossrefPubMedGoogle Scholar
  • 22 Biró E, Lok C A, Hack C E et al. Cell-derived microparticles and complement activation in preeclampsia versus normal pregnancy.  Placenta. 2007;  28(8–9) 928-935
    CrossrefPubMedGoogle Scholar
  • 23 Shah M D, Bergeron A L, Dong J F, López J A. Flow cytometric measurement of microparticles: pitfalls and protocol modifications.  Platelets. 2008;  19(5) 365-372
    CrossrefPubMedGoogle Scholar
  • 24 Harrison P, Dragovic R, Albanyan A, Lawrie A S, Murphy M, Sargent I. Application of dynamic light scattering to the measurement of microparticles.  J Thromb Haemost. 2009;  7(Suppl 2) , Abstract OC-TU-056
    PubMedGoogle Scholar
  • 25 Lawrie A S, Albanyan A, Cardigan R A, Mackie I J, Harrison P. Microparticle sizing by dynamic light scattering in fresh-frozen plasma.  Vox Sang. 2009;  96(3) 206-212
    CrossrefPubMedGoogle Scholar
  • 26 Chu B. Laser Light Scattering: Basic Principles and Practice. 2nd ed. Boston, MA; Academic Press 1991
    Google Scholar
  • 27 Pecora R. Dynamic Light Scattering: Applications of Photon Correlation Spectroscopy. New York, NY; Plenum Press 1985
    Google Scholar
  • 28 Schmitz K S. An Introduction to Dynamic Light Scattering by Macromolecules. New York, NY; Academic Press 1990
    Google Scholar
  • 29 Johnson C S, Gabriel D A. Laser Light Scattering. New York, NY; Dover Publications 1994
    Google Scholar
  • 30 Jones C R, Johnson Jr C S, Penniston J T. Photon correlation spectroscopy of hemoglobin: diffusion of oxy-HbA and oxy-HbS.  Biopolymers. 1978;  17(6) 1581-1593
    CrossrefPubMedGoogle Scholar
  • 31 Maurer-Spurej E, Labrie A, Pittendreigh C et al. Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies.  Transfusion. 2009;  49(11) 2276-2284
    CrossrefPubMedGoogle Scholar
  • 32 Maurer-Spurej E, Brown K, Labrie A, Marziali A, Glatter O. Portable dynamic light scattering instrument and method for the measurement of blood platelet suspensions.  Phys Med Biol. 2006;  51(15) 3747-3758
    CrossrefPubMedGoogle Scholar
  • 33 Mauer-Spurej E, Labrie A, Brown K. Routine quality testing of blood platelet transfusions with dynamic light scattering.  Part Part Syst Char. 2008;  25 99-104
    CrossrefPubMedGoogle Scholar
  • 34 Li X, Gabriel D A. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.  Biochemistry. 1997;  36(35) 10760-10767
    CrossrefPubMedGoogle Scholar
  • 35 Ware B R. Electrophoretic light scattering.  Adv Colloid Interface Sci. 1974;  4 1
    CrossrefPubMedGoogle Scholar
  • 36 Smoluchowski M. Molekular-kinetische Theorie der Opaleszenz von Gasen in kritischen Zustande sowie einiger verwandter Erscheinungen.  Ann Phys. 1908;  25 205-226
    PubMedGoogle Scholar
  • 37 Melton L G, Li T, Stafford D W, Gabriel D A. Location of the platelet binding site in zymogen coagulation factor IX.  Blood Coagul Fibrinolysis. 2001;  12(4) 237-243
    CrossrefPubMedGoogle Scholar
  • 38 Jorgenson J W, Lukacs K D. Free-zone electrophoresis in glass capillaries.  Clin Chem. 1981;  27(9) 1551-1553
    PubMedGoogle Scholar
  • 39 Xiong G, Aras O, Shet A, Key N S, Arriaga E A. Analysis of individual platelet-derived microparticles, comparing flow cytometry and capillary electrophoresis with laser-induced fluorescence detection.  Analyst (Lond). 2003;  128(6) 581-588
    CrossrefPubMedGoogle Scholar
  • 40 Kunicka J E, Fischer G, Murphy J, Zelmanovic D. Improved platelet counting using two-dimensional laser light scatter.  Am J Clin Pathol. 2000;  114(2) 283-289
    CrossrefPubMedGoogle Scholar

Don A GabrielM.D. Ph.D. 

Division of Hem/Onc, BMT Program, POB – 3rd Floor

UNC School of Medicine, Chapel Hill, NC 27599

Email: dgabriel@invitrox.com

      >